Total Payments
$6,891
2024 Payments
$430.60
Companies
39
Transactions
353
Medicare Patients
496
Medicare Billing
$48,477
Payment Breakdown by Category
Food & Beverage$6,891 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,891 | 353 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,450 | 69 | $0 (2024) |
| Novo Nordisk Inc | $636.57 | 34 | $0 (2024) |
| Lilly USA, LLC | $613.37 | 29 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $444.02 | 23 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $398.57 | 21 | $0 (2023) |
| PFIZER INC. | $345.76 | 24 | $0 (2023) |
| Merck Sharp & Dohme LLC | $342.69 | 19 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $245.02 | 17 | $0 (2022) |
| Amgen Inc. | $237.97 | 9 | $0 (2023) |
| NESTLE HEALTHCARE NUTRITION INC. | $231.04 | 10 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $430.60 | 21 | ABBVIE INC. ($167.86) |
| 2023 | $1,358 | 65 | AbbVie Inc. ($596.65) |
| 2022 | $1,431 | 71 | ABBVIE INC. ($256.87) |
| 2021 | $1,250 | 68 | AbbVie Inc. ($242.22) |
| 2020 | $773.33 | 42 | Novo Nordisk Inc ($143.74) |
| 2019 | $495.67 | 24 | Gilead Sciences, Inc. ($106.68) |
| 2018 | $776.31 | 37 | Lilly USA, LLC ($162.81) |
| 2017 | $375.01 | 25 | Valeant Pharmaceuticals North America LLC ($82.64) |
All Payment Transactions
353 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.41 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: RESPIRATORY | ||||||
| 05/09/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Cardio-renal | ||||||
| 04/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Respiratory | ||||||
| 04/03/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: OUD | ||||||
| 03/27/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Diabetes | ||||||
| 03/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: NEUROSCIENCE | ||||||
| 02/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: NEUROSCIENCE | ||||||
| 02/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Cardio-renal | ||||||
| 02/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Respiratory | ||||||
| 02/14/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Obesity | ||||||
| 02/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Gastroenterology | ||||||
| 02/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: VACCINE | ||||||
| 01/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.87 | General |
| Category: NEUROSCIENCE | ||||||
| 01/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: NEUROSCIENCE | ||||||
| 01/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Respiratory | ||||||
| 01/10/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: OUD | ||||||
| 12/21/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: NEUROSCIENCE | ||||||
| 12/20/2023 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Diabetes | ||||||
| 12/19/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/14/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 197 | 301 | $77,600 | $19,283 |
| 2022 | 4 | 134 | 186 | $51,940 | $12,269 |
| 2021 | 4 | 135 | 219 | $58,255 | $15,023 |
| 2020 | 1 | 30 | 45 | $9,000 | $1,902 |
Total Patients
496
Total Services
751
Medicare Billing
$48,477
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 80 | 148 | $36,880 | $7,655 | 20.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 48 | 78 | $25,350 | $6,313 | 24.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 34 | 34 | $11,900 | $4,483 | 37.7% |
| 99347 | Residence visit for established patient with straightforward medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 15 | 20 | $2,000 | $665.74 | 33.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 20 | 21 | $1,470 | $165.48 | 11.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 64 | $20,800 | $4,784 | 23.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 28 | 28 | $9,800 | $3,823 | 39.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 56 | 82 | $20,500 | $3,578 | 17.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 12 | $840.00 | $84.20 | 10.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 63 | 129 | $32,150 | $7,247 | 22.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 37 | 55 | $17,775 | $4,769 | 26.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 21 | 21 | $7,350 | $2,907 | 39.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 14 | 14 | $980.00 | $99.60 | 10.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 30 | 45 | $9,000 | $1,902 | 21.1% |
About Dr. Haldor Barnes, M.D
Dr. Haldor Barnes, M.D is a Family Medicine healthcare provider based in Mashpee, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861428849.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Haldor Barnes, M.D has received a total of $6,891 in payments from pharmaceutical and medical device companies, with $430.60 received in 2024. These payments were reported across 353 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($6,891).
As a Medicare-enrolled provider, Barnes has provided services to 496 Medicare beneficiaries, totaling 751 services with total Medicare billing of $48,477. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Mashpee, MA
- Active Since 06/23/2006
- Last Updated 03/10/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1861428849
Products in Payments
- VRAYLAR (Drug) $785.08
- UBRELVY (Drug) $275.44
- ZENPEP (Drug) $231.04
- Livalo (Drug) $230.81
- Trintellix (Drug) $212.40
- Aimovig (Biological) $201.99
- Ozempic (Drug) $201.44
- Kerendia (Drug) $198.82
- TRINTELLIX (Drug) $187.91
- Rybelsus (Drug) $186.57
- FARXIGA (Drug) $179.54
- EMGALITY (Drug) $171.87
- COLOGUARD DNA CAPTURE REAGENTS (Device) $163.72
- NURTEC ODT (Drug) $160.35
- Synthroid (Drug) $158.41
- TRELEGY ELLIPTA (Drug) $147.30
- TRULICITY (Drug) $138.52
- SUBLOCADE (Drug) $131.84
- MOUNJARO (Drug) $127.22
- FORTEO (Drug) $113.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Mashpee
Dr. Rocco Rossi, Do, DO
Family Medicine — Payments: $11,067
Family Medicine $11,067
George Silva
Family Medicine — Payments: $2,961
Family Medicine $2,961
Julia Craig-Muller, Md, MD
Family Medicine — Payments: $382.95
Family Medicine $382.95
Dr. Mary-Amanda O'neill, M.d, M.D
Family Medicine — Payments: $173.30
Family Medicine $173.30
Dr. Kristy Brown, D.o, D.O
Family Medicine — Payments: $172.28
Family Medicine $172.28
Dr. Stephanie Prior, M.d, M.D
Family Medicine
Family Medicine